Cargando…

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers

Blood disorders include a wide spectrum of blood-associated malignancies resulting from inherited or acquired defects. The ineffectiveness of existing therapies against blood disorders arises from different reasons, one of which is drug resistance, so different types of leukemia may show different r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sajjadi-Dokht, Mehdi, Merza Mohamad, Talar Ahmad, Sulaiman Rahman, Heshu, Suliman Maashi, Marwah, Danshina, Svetlana, Shomali, Navid, Solali, Saeed, Marofi, Faroogh, Zeinalzadeh, Elham, Akbari, Morteza, Adili, Ali, Aslaminabad, Ramin, Farshdousti Hagh, Majid, Jarahian, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170603/ https://www.ncbi.nlm.nih.gov/pubmed/35685482 http://dx.doi.org/10.1016/j.gendis.2021.10.009

Ejemplares similares

The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
por: Zeinalzadeh, Elham, et al.
Publicado: (2021)

Correction: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
por: Shomali, Navid, et al.
Publicado: (2022)

Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape
por: Jarahian, Mostafa, et al.
Publicado: (2021)

Anastasis: cell recovery mechanisms and potential role in cancer
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Correction: Anastasis: cell recovery mechanisms and potential role in cancer
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro
por: Alkafaji, Haider A., et al.
Publicado: (2021)

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
por: Mardi, Amirhossein, et al.
Publicado: (2022)

Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements
por: Rahbaran, Mohaddeseh, et al.
Publicado: (2021)

Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

Epigenetic mechanisms as a new approach in cancer treatment: An updated review
por: Fardi, Masoumeh, et al.
Publicado: (2018)

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
por: Marofi, Faroogh, et al.
Publicado: (2021)

Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)

A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review
por: Sharafi, Faezeh, et al.
Publicado: (2022)

MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
por: Faeq, Mohammed Hikmat, et al.
Publicado: (2023)

CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities
por: Hassanzadeh, Ali, et al.
Publicado: (2021)

An investigation of methylation pattern changes in the IKZF1 promoter in patients with childhood B-cell acute lymphoblastic leukemia
por: Rahmani, Mina, et al.
Publicado: (2019)

Investigating the expression pattern of the angiopoietin-Tie system in ALL and its correlation with baseline characteristics
por: Khosravi, Saeed Zaka, et al.
Publicado: (2021)

Promoter Methylation Status of Survival-Related Genes in MOLT- 4 Cells Co-Cultured with Bone Marrow Mesenchymal Stem Cells under Hypoxic Conditions
por: Ahani-Nahayati, Milad, et al.
Publicado: (2018)

Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy
por: Hassanzadeh, Ali, et al.
Publicado: (2021)

A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021)

Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways
por: Shojaei Moghadam, Kobra, et al.
Publicado: (2020)

Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
por: Budi, Hendrik Setia, et al.
Publicado: (2022)

Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease
por: Hosseini, Arezoo, et al.
Publicado: (2020)

Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
por: Razeghian, Ehsan, et al.
Publicado: (2021)

Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022)

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
por: Markov, Alexander, et al.
Publicado: (2021)

Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol
por: Nakhaei, Pooria, et al.
Publicado: (2021)

Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
por: Widjaja, Gunawan, et al.
Publicado: (2021)

Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019
por: Mohammadhosayni, Mina, et al.
Publicado: (2021)

Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell
por: Shojaei Baghini, Sadegh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6pdasn6ejvki06nk9nv3eu01n2